FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.

Web giant and partner CTC Global assert advanced conductors can double heavy-duty power line capacity in months versus a ...

The federal government recently unveiled its One Canadian Economy Act, one of the first major pieces of legislation tabled by ...

The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have ...

Southern Company's 60-year bond offers a 6.3% yield, nearly double its stock dividend, ideal for income investors seeking ...

To test the limits, the researchers started by firing a powerful, ultrafast laser into the side of a volunteer’s head. The ...

The Focus on Sickle Cell Foundation (FoSCel) held a National Forum on Thursday, June 19, at the Jophus Anamuah-Mensah Conference Centre, University of Education, Winneba (UEW), drawing together ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

At a recent roundtable discussion in Rosebank, experts warned that outdated regulations and red tape could dim the country’s ...

General Motors' CFO Paul Jacobson made the remarks last week at the Deutsche Bank Global Auto Industry Conference.